Vimarsana
Biggest News Aggregation in the World

Founding Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Founding Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Founding Professor Today - Breaking & Trending Today

'Learn How To Pronounce Names' – Columbia Professor's Public Shaming At JNU Lecture Goes Viral - Vimarsana News

'Learn How To Pronounce Names' – Columbia Professor's Public Shaming At JNU Lecture Goes Viral

A recent lecture by literary critic Gayatri Chakravorty Spivak at JNU sparked a controversy after a video surfaced of a heated verbal argument between her with an audience member over pronunciation.

Gayatri Chakravorty Spivak's Heated Exchange with Audience Member at JNU Lecture Sparks Debate - Vimarsana News

Gayatri Chakravorty Spivak's Heated Exchange with Audience Member at JNU Lecture Sparks Debate

The confrontation occurred when Kumar raised a question, but Spivak continuously interrupted him and corrected his pronunciation of W.E.B. Du Bois

Source: news18.com
Educating the educators – why the UK's engineering teachers need reskilling too | Engineering and Technology Magazine - Vimarsana News

Educating the educators – why the UK's engineering teachers need reskilling too | Engineering and Technology Magazine

Reskilling and upskilling the engineering workforce is frequently discussed in conjunction with topics like AI and sustainability, both of which were highlighted during the recent World Engineering Education Forum (WEEF) held in Monterrey, Mexico.

Source: theiet.org
Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa - Vimarsana News

Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa

Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis SuppurativaBimekizumab treatment resulted in clinically meaningful improvements in HiSCR50 and the more stringent endpoints HiSCR75, HiSCR90 and HiSCR100 vs. placebo at Week 16, with improvem...

UCB : Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa -October 12, 2023 at 12:03 pm EDT - Vimarsana News

UCB : Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa -October 12, 2023 at 12:03 pm EDT

Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa Bimekizumab...